Skip to content
Screener

Guardian Pharmacy Services GRDN Business Segments — Profit Loss

Similar metrics at other companies

BioSig Technologies, Inc. logo
STEXCorporate — Profit Loss
-$46.69M-1,561%
Walker & Dunlop logo
WDCorporate — Profit Loss
-$35.21M+4.1%
Flanigan's Enterprises logo
BDLCorporates — Profit Loss
-$2.36M+0.4%
Comstock Inc. logo
LODECorporate And Other — Profit Loss
-$1.38M+60.9%
MillerKnoll logo
MLKNProfit Loss
$24.9M+144%
Cal-Maine Foods logo
CALMProfit Loss
$51.12M-89.9%

Other financials

Income statement

See full
Revenue$351.8M+2.2%
Gross profit$80.0M+17.5%
Operating income$20.6M+64.1%
Net income$21.9M+142%
EPS (diluted)$0.34+143%

Balance sheet

See full
Cash & equivalents$89.8M+377%
Total debt$35.2M+4.6%
Total equity$257.6M+43.4%
Total assets$443.6M+24.5%

Cash flow

See full
Operating cash flow$30.0M+50.6%
CapEx$495.0K-78.0%
Free cash flow$34.1M+69.8%

Valuation

See full
Market cap$2.5B+88.6%
Enterprise value$2.44B+82.4%
P/E37.9×
P/S1.7×+0.7×

Profitability

See full
Gross margin21.6%+2.0pp
Operating margin5.8%
Net margin4.5%+2.8pp

Returns & leverage

See full
Return on equity30.1%
Debt / equity0.1×-0.1×
Current ratio1.7×+0.5×

Where this comes from

Reported directly by Guardian Pharmacy Services in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The source filing: Guardian Pharmacy Services’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:17 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-338074
(In thousands, except per share amounts)Three Months Ended June 30, 2025Three Months Ended June 30, 2026Six Months Ended June 30, 2025Six Months Ended June 30, 2026
Total other expenses (income)(7)(9,148)(108)(9,766)
Income before income taxes12,58729,79225,69348,085
Provision for income taxes3,7607,6717,59312,420
Net income8,82722,12118,10035,665
Less net income (loss) attributable to non-controlling interests(203)249(378)498
Net income attributable to Guardian Pharmacy Services, Inc.$9,030$21,872$18,478$35,167
Net income per share of Class A and Class B common stock1
Basic$0.15$0.35$0.30$0.56

ITEM 1. Financial Statements

FAQ

What is Guardian Pharmacy Services's business segments — profit loss?
Guardian Pharmacy Services (GRDN) reported business segments — profit loss of $22.12M in Q2 2026.
How has Guardian Pharmacy Services's business segments — profit loss changed year-over-year?
Guardian Pharmacy Services's business segments — profit loss increased by 150.6% year-over-year, from $8.83M to $22.12M.
What does business segments — profit loss mean?
Indicates the net financial result of the corporate segment after all revenues and operating expenses are accounted for. It is the primary measure of the segment's operational success and its ability to generate value for the parent organization.

Ask your AI about Guardian Pharmacy Services's business segments — profit loss.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude